Background: Despite advances in our understanding of the mechanisms of influenza A virus (IAV) infection, the crucial virus-host interactions during the viral replication cycle still remain incomplete. Tetraspanin CD151 is highly expressed in the human respiratory tract, but its pathological role in IAV infection is unknown.
Objectives: We sought to characterize the functional role and mechanisms of action of CD151 in IAV infection of the upper and lower respiratory tracts with H1N1 and H3N2 strains. Methods: We used CD151-null mice in an in vivo model of IAV infection and clinical donor samples of in vitro-differentiated human nasal epithelial cells cultured at air-liquid interface. The estimated annual global burden of interpandemic influenza is of the order of 1 billion, with 3 to 5 million cases of severe illness and up to 650,000 deaths.
1 Current antiviral drugs for influenza A virus (IAV) are effective in reducing severe complications and deaths only when administered early in the disease, while vaccines need to be well matched against circulating viruses to confer protection. Furthermore, there is a rising number of drug-resistant influenza strains against current antivirals that severely hamper our ability to respond to influenza outbreaks. 2 Therefore, targeting conserved host components critical for the life cycle of the virus can greatly increase the genetic barrier of resistance, thus rendering this approach an attractive alternative or complementary strategy for the development of novel antiviral drugs.
CD151 belongs to the superfamily of 4-transmembrane glycoproteins called tetraspanins that associates selectively with laminin-binding integrins 3, 4 and is expressed abundantly in the lungs. 3 It serves as a docking site for intracellular signaling proteins, and has been implicated in physiological and pathological events including cell growth, apoptosis, migration, and metastasis. 5, 6 Tetraspanins have also been implicated in contributing to different phases of virus life cycle. [7] [8] [9] [10] [11] However, there are no studies to date that examined whether CD151 plays a role in IAV infection and none have implicated a functional role of CD151 in viral protein nuclear export and innate immunity against the virus. Thus, we aim to address this knowledge gap by fully characterizing CD151's role in IAV infection of the upper and lower respiratory tracts across virus strains, from in vivo mice model and in vitro clinical donor samples.
METHODS Reagents
All chemicals used were of analytical grade or higher. All compounds were purchased from Sigma (St Louis, Mo) unless stated otherwise.
Inoculation of H1N1 ((PR)/8/34) virus in wild-type and CD151
2/2 mice
All animal work was conducted in accordance with the National University of Singapore Institutional Animal Care and Use Committee guidelines (under the protocol R13-5513). Eight-to 12-week-old wild-type (WT) mice C57BL/6 (age-and sex-matched; In Vivos, Singapore) and CD151 2/2 adult mice 4 (gift from Professor Leonie Ashman, University of Newcastle) were inoculated with 50 mL of 50 plaque-forming units (PFUs) of influenza H1N1 A/Puerto Rico/8/34 mouse-adapted virus (American Type Culture Collection [ATCC], Manassas, Va) by intratracheal instillation, whereas the uninfected controls were instilled with the same amount of PBS as previously described. 12 In the survival study, for a period of 14 days, mice (7 mice/treatment group) were weighed and monitored daily for mortality (30% weight loss from original weight, in accordance with Institutional Animal Care and Use Committee guidelines). At 3, 5, 7, and 9 days postinfection (dpi), another batch of WT and CD151 2/2 mice (4-7 mice/treatment group) was euthanized by overdose of anesthesia. Immediately thereafter, the right upper lung lobes of the mice were collected, with 30% of the lung lobe excised and homogenized for virus plaque assay and the rest stored in liquid nitrogen for RNA and protein assays.
Lung histology
The left lobes of the lungs were fixed in formalin and stained with hematoxylin and eosin, as previously described, 4 and scored histologically for lung damage. Histological damage was scored by an experienced pathologist on the basis of the following formula: [alveolar hemorrhage 1 2 (alveolar infiltrates) 1 3 (fibrin) 1 alveolar septal congestion], where the 4 criteria were each scored on a scale of 0 to 3. 13 
Virus plaque assay
Madin-Darby canine kidney cells (95% confluent) in 24-well plates were incubated with 100 mL of serial dilutions ranging from 10 1 to 10 4 of 1 mg/mL trypsin-TPCK activated virus samples from infected mouse lung homogenate or human nasal epithelial cell (hNEC) culture medium (refer to in vitro study) at 358C with 5% CO 2 for 1 hour. Plates were rocked every 15 minutes to ensure equal distribution of virus. The inoculums were removed and replaced with 1 mL of 1.2% Avicel overlay to each well and incubated at 358C with 5% CO 2 for 65 to 72 hours. Avicel overlay was then removed, and cells were fixed with 4% formaldehyde in PBS for 1 hour. Formaldehyde was removed and cells washed with PBS. Fixed cells were stained with 1% crystal violet for 15 minutes and washed with running water. Plates were air-dried at room temperature and the PFU was calculated as follows: Number of plaques 3 dilution factor 5 Number of PFUs per 100 mL.
14

Western blotting
Protein lysates of mouse lungs or hNECs were prepared as described previously 4, 14 and lung tissues were homogenized in ice-cold lysis buffer (100 mM NaCl; 10 mM Tris-HCl, pH 7.5; 2 mM EDTA; 0.5% w/v 
Total RNA extraction and reverse transcription
Total RNAwas extracted from H1N1-infected WTand CD151 2/2 mice lung or H3N2-infected hNECs using RNeasy RNA extraction kit (QIAGEN, Hilden, Germany) following the manufacturer's protocol. The concentration and quality of total RNA were determined by Nanodrop2000 UV-Vis Spectrophotometer (ThermoScientific, Pittsburgh, Pa). RNA (2 mg each) was subjected to cDNA synthesis using the M-MLV reverse transcriptase (ThermoScientific).
Quantitative real-time PCR detection of viral and host immune response genes
Quantitative PCR (qPCR) analysis was performed to evaluate the transcriptional levels of host immune response genes. The primers for SYBR green-based qPCR were designed (see Tables E1 and E2 in this article's Online Repository at www.jacionline.org), preoptimized, and synthesized by Sigma-Aldrich (Singapore). The qPCRs were performed in duplicate using GoTaq-qPCR Master Mix kit (Promega, San Luis Obispo, Calif), and thermal cycling was carried out with a Viia 7 PCR machine (Life Technologies). Relative gene expression was calculated using the comparative method 2 2DDCt by normalizing to the house-keeping Rpl13a and glyceraldehyde 3-phosphate dehydrogenase mRNA levels, for mice and hNECs, respectively. qPCR analysis was performed to evaluate the transcriptional level of viral M, NP, and NS genes. All 3 viral genes are full-length cDNAs (ie, NS1 5 NS1 and NS2; M1 5 M1 and M2; NP 5 NP). 14, 15 The primers for SYBR green-based qPCR were synthesized by Sigma-Aldrich (Table E1 ). The qPCR reactions were set up in duplicate using GoTaq-qPCR Master Mix kit (Promega) and qPCR reactions were performed on Viia 7 PCR machine (Life Technologies). Melting curves were analyzed to determine the specificity of each reaction to the target. Median and interquartile values were then calculated.
Primary hNECs culture and differentiation at air-liquid interface institutional review board code 13-509). Adult patients were recruited from the Department of Otolaryngology, National University Health System (Singapore). Human nasal epithelial stem/progenitor cells were isolated and expanded from fresh nasal specimens, and the hNECs were differentiated in vitro via air-liquid interface (ALI) culture to become ciliated cells within 32 days as previously described. 14, 16 Gene silencing by small interfering RNA Small interfering (siRNA) transfection was carried out when hNECs in ALI culture were fully differentiated. A commercially available siRNA kit from Dharmacon (Lafayette, Colo) was used. 4 The CD151 siRNA contained a smart pool of 4 target sequences GAUCAUCGCUGGUAUCCUC, GCAA GACGGUGGUGGCUCU, CCUCAAGAGUGACUACAUC, and UCACAG GACUGGCGAGACA. Cells were transfected on 2 consecutive days with CD151 siRNA (25 nM) using DharmaFECT1 or ON-TARGETplus Non-Targeting pooled siRNA (25 nM, negative control), which was added to both the apical (200 mL) and basal (300 mL) chambers. Knockdown efficiency was determined by Western blotting and immunofluorescence staining intensity.
Cell viability assay
The LIVE/DEAD cell viability assay (Life Technologies, Invitrogen, Singapore) was used to visualize and evaluate the cytotoxicity of CD151 siRNA treatment before H3N2 infection. The hNECs in ALI culture were incubated with equal volume of CYTO-9 and propidium iodide dyes for 10 minutes at 378C, followed by washing twice with Dulbecco phosphatebuffered saline (DPBS). The live hNECs were stained by CYTO-9 dye and displayed intact green cell membrane, whereas the dead cells were stained by propidium iodide and exhibited red nuclear staining under fluorescence microscopy. Four random fields of cells were selected per treatment group, and the number of dead cells (stained positive by propidium iodide) was quantified by the CellSens Dimension software (Olympus, Tokyo, Japan).
Infection of H3N2 (Aichi/2 strain) virus in fully differentiated hNECs
The in vitro-differentiated hNECs cultured on Transwell inserts were washed once with 50 mL of DPBS at 378C for 10 minutes, and these diluents were collected and stored as the ''mock-control'' supernatant for virus plaque assay. Forty-eight hours after the first CD151 siRNA transfection, hNECs were infected with the human influenza H3N2 (Aichi/2) virus strain (ATCC), propagated in eggs, and titrated by plaque assay using Madin-Darby canine kidney cells (ATCC). The virus was thawed on ice and immediately diluted in 100 mL of B-ALI differentiation medium with a multiplicity of infection of 0.1, inoculated into the apical chamber of Transwells, and incubated at 358C for 1 hour. The total cell number was determined by trypsinization of hNECs and cell counting using a hematocytometer, and for calculation of multiplicity of infection. After virus inoculation, the Transwells were transferred into a new 24-well plate containing 350 mL of B-ALI differentiation medium in the basal chamber. The infected and mock-infected hNECs were then incubated at 358C with 5% CO 2 for 24 hours postinfection. The cultured medium was then incubated in the apical chamber for 10 minutes at 358C to collect the progeny viruses for subsequent plaque assay.
Immunofluorescence staining of hNECs and mouse lung tissue
Transwell membranes were fixed with 4% paraformaldehyde for 20 minutes and cut into pieces before immunofluorescence staining. After permeabilization using 0.1% Triton X-100 at room temperature for 15 minutes, Transwell membranes were blocked with Image-iT FX signal enhancer reagent (Life Technologies, Singapore) and blocking buffer (5% goat serum with 1% BSA) at room temperature for 30 minutes consecutively. Biotechnology, Inc), total a-tubulin (1:100 dilution, Santa Cruz Biotechnology, Inc), acetylated a-tubulin (1:800 dilution, Abcam), and b4-tubulin (1:800 dilution, Abcam) were diluted in blocking buffer. After overnight incubation of primary antibodies at 48C and washing thrice with PBST (0.2% tween) secondary antibodies (1:200 dilutions, Life Technologies) were added and incubated for 1 hour at room temperature, followed by washing thrice with PBST. Respective samples were stained with phalloidintetramethylrhodamine isothiocyanate (1:1000 dilution) for 45 minutes, diluted in PBS. Finally, Transwell membranes were stained with 10 mg/mL Hoechst nuclear stain for 45 seconds before coverslips were mounted using the ProLong AntiFade mounting medium (Life Technologies). The stained cells were visualized with Olympus FluoView FV10i (Olympus) laser-scanning confocal microscope using a 603 objective, with 543 nm HeNe laser as the excitation source. For analysis, 100 cells with intact nucleus per treatment group were quantified for nuclear/cytoplasm staining of the various proteins (CRM1, NP, M1, NEP, and NS1). The intensities of a, b4-tubulin, and F-actin were measured after keeping all fluorescence settings fixed across samples. All measurements were normalized over the nontargeting control.
Immunofluorescence staining of mouse lung tissues was performed on 5-mm-thick lung sections. Lung slides were dewaxed in xylene and rehydrated in descending concentrations of ethanol to distilled water, then followed by antigen retrieval in citric sodium solution (Vector H3300) and heating for 10 minutes at 958C. After washing briefly in water, the sections were permeabilized with 0.3% of Triton-X 100 for 20 minutes, and Image iT-FX (Invitrogen) was added to enhance the signals. The sections were then blocked in 5% goat serum and 1% BSA with 0.3% of Triton-X 100 for 1 hour. After washing in PBS, the sections were incubated overnight with anti-NP rabbit primary antibody (1:100 dilution, Abcam). On the second day, the slides were incubated with Alexa Fluor 488 goat anti-rabbit IgG (Thermo Fisher Scientific) (1:200 dilution in PBS with 1% goat serum) for 1 hour. This was followed by nuclear staining with Hoechst 33258 for 45 seconds. After intense washing in PBS, the slides were mounted with Prolong Gold Antifade (Life Technologies) and stored in the dark at 48C till required. The TissueFAX Scanner (TissueGnostics, Vienna, Austria) was used to scan the lung sections at 203 magnification, and the Olympus FV1000 confocal microscope was used to acquire representative images under 1003 and 603 magnification.
Immunoprecipitation
Immunoprecipitation was carried out with anti-CD151, anti-CRM1, anti-NP, anti-M1, anti-hemagglutinin, or anti-IgG 1 isotype control antibodies (1 mg) in the presence of 30 mL of protein G-Sepharose (GE Healthcare, Singapore) for 2 hours at 48C in ice-cold lysis buffer. The beads were then washed thrice with lysis buffer, with 10% BSA and 300 mg of solubilized cell lysates (mock and H3N2-infected hNECs) added, and the mixture incubated for 2 hours at 48C. The immunoprecipitate obtained was analyzed on a 12% SDS-polyacrylamide gel as described above. Twenty microgram of protein lysates was included as input controls.
Cytokine/chemokine protein expression by luminex analysis
Luminex assay was carried out by Immunomonitoring Laboratory (Singapore Immunology Network), using the serum collected from H1N1-infected WT and CD151 2/2 mice at 5 and 7 dpi. Protein levels of IL-6, TNF-a, CXCL10/IP-10, CCL2/MCP-1, and CCL5/RANTES were selected from Millipore chip (Millipore, Burlington, Mass), according to the significantly upregulated markers screened by qPCR and previous reports of H1N1-infected mice. 17, 18 13 DPBS buffer was used as blank control. Sample processing and data analysis were performed using Bioplex Manager 6.0 software. Readings were calculated according to the standard curves for each marker.
Infection of human bronchial epithelial cells with polyinosinic-polycytidylic
Human bronchial epithelial cell line, BEAS-2B (ATCC), was cultured in Dulbecco modified Eagle medium supplemented with 10% FBS and seeded into 6-well plates at a density of 5 3 10 4 /well. Cells (at 50% confluence) were then transfected with nontargeting siRNA or CD151 siRNA (12.5 nM), with transfection agent alone used as vehicle control. Following 48 hours of post-siRNA transfection, cells were treated with 10 mg/mL polyinosinic-polycytidylic (Poly (I:C); Sigma-Aldrich); or saline as vehicle control) to stimulate antiviral responses in a virus-free condition. RNA was collected at 2, 4, and 24 hours after Poly (I:C) treatment for measurement of IFNb, CXCL10/IP-10, and IL-1b gene expression by qRT-PCR analysis.
Statistical analysis
Statistical differences for multiple-individual-derived hNECs were evaluated by Student paired t test (2-tailed), and statistical differences for protein abundance and virus titer in mice were evaluated by 2-way ANOVA followed by uncorrected Fisher least significant difference to determine significant differences at a P value of less than .05 (Graphpad Prism 6 software, La Jolla, Calif). The difference in survival rate of WT and CD151 2/2 mice was evaluated using Kaplan-Meier log-rank test. Data are expressed as mean 6 SEM.
RESULTS
Lack of CD151 improves survival rate and reduces virus titer
Following a low lethal dose of IAV (mouse-adapted PR8/H1N1) at 50 PFUs, 14% of the CD151 2/2 mice succumbed to the infection compared with WT mice (85%) at the end point of the survival study of 14 days (Fig 1, A) . The lengthened survival time could be attributed to reduced disease manifestation observed from earlier recovery of body weight loss (Fig 1, B) and slower peaking of viral titer, showing significantly reduced titer at 3 dpi (where viral infection normally peaks) and early decrease at 9 dpi (where clearance of the virus typically occurs) (P < .05; Fig 1, C) . Interestingly, the reduction in viral titer correlates only with certain viral proteins at specific time points, such as M1 (P < .05) and NP (P 5 .06) (Fig 1, D, E , and H), whereas NEP and NS1 were unchanged (Fig 1, F-H) . In agreement with protein data, reduced viral titer at early time points (3 dpi) was not explained by reduced viral mRNA levels (see Fig E1 in J ALLERGY CLIN IMMUNOL VOLUME 141, NUMBER 5 Lack of CD151 increases nuclear localization of viral NP at the epithelial cell layer
We further explored possible mechanisms by which CD151 could be mediating its effects on the IAV life cycle by using immunofluorescence microscopy to track viral protein translocation in WT and CD151 2/2 mice. At 3 dpi, the NP-positive staining was more dispersed in the WT mice, whereas in CD151 2/2 -infected mice, NP staining was mainly concentrated in the bronchial epithelial cell layer (Fig 2, A) , suggesting diminished virus propagation into the lungs. This was accompanied by increased NP nuclear staining ratio, indicating prolonged nuclear retention of viral ribonucleoproteins (vRNPs) with reduced nuclear export (Fig 2, B) . In addition, the translocation of NS1 (which does not associate with vRNPs) was similar in infected WT and CD151 2/2 mice (see Fig E2, A, in this article's Online Repository at www.jacionline.org), suggesting a key role for CD151 in nuclear shuttling of vRNPs. Moreover, we observed no difference in NP translocation in the lungs of infected 
CD151
2/2 mice compared with WT mice at 1 dpi (Fig E2, B) , indicating that there was no deficiency in viral protein nuclear entry during the initial infection stages of CD151 2/2 mice. Also, viral titers of infected WT and CD151 2/2 mice were not different (Fig E2, C) . Notably, at 5 and 7 dpi, there was no significant difference in both the expression and nuclear localization of viral proteins (Fig E2, D-F) , indicating that alternative pathways may compensate for the lack of CD151 at this stage of virus infection. At 9 dpi, both virus titer and NP staining were reduced in lungs of infected CD151
2/2 mice, suggesting enhanced viral clearance (Fig 2, C) . This further supports a critical role for CD151 in the later stage of virus life cycle.
Lack of CD151 leads to delayed but more pronounced host antiviral response
The interaction between virus infection and the host immune response is one of the key determinant factors in IAV virulence. At early infection stage (3 dpi), CD151 2/2 mice exhibited similar transcript levels for antiviral host genes, that is, IFN-b, IFN-g, and IFN-inducible transmembrane proteins IFITM1 and IFITM3 (Fig 3, A-D) . However, at 5 dpi, these host factors were significantly elevated in lungs of CD151 2/2 mice. Interestingly, IFN-stimulated gene 15 was significantly lower in CD151 2/2 mice at 3 dpi, but quickly reverted to similar levels as WT mice later during IAV infection (Fig 3, E) . This observation suggests a delayed but more potent host antiviral response when CD151 is absent during the intermediate stage of IAV infection.
An inflammatory response that is elevated, but acute and well regulated, can have a protective effect in response to harmful stimuli such as IAV infection. Concomitant with the increased host immune response, inflammatory gene markers IP-10, CCL2, CCL5, IL6, and IL-13 (except TNF-a) were significantly lower in infected CD151
2/2 mice at 3 dpi (Fig 3, F-K) , consistent with the reduced progeny virus titer (Fig 1, C) for this time point. By 5 dpi, IP-10, TNF-a, MCP-1, RANTES, and IL-6 were significantly elevated in infected CD151 2/2 mice compared with infected WT mice. We confirm that expression profiles of the above genes were similar in mock-infected control WT and CD151 2/2 mice at baseline (see Fig E3 in this article' s Online Repository at www.jacionline.org). In support, changes in gene expression were also observed at the protein level (see Fig E4 in this article' s Online Repository at www.jacionline.org). In CD151 2/2 mice, the mRNA expression of many key cytokines/chemokines was higher at 5 dpi, whereas the protein levels of certain cytokines/chemokines (eg, IL-6, TNF-a, and IP-10) was higher at 7 dpi (Fig E4, A-C) . Interestingly, as compared with WT infected mice, consistently higher IL-6 protein levels in both serum (Fig E4, A) and bronchoalveolar lavage fluid of infected CD151 2/2 mice were observed (CD151
2/2
: 2682 6 411 pg/mL vs WT mice: 3907 6 198 pg/mL; P < .05 at 5 dpi). IL-6 is a key cytokine involved in orchestrating antiviral immunity via its role in limiting inflammation and protecting the host against virus-induced lung injury. 19 Taken together, these cytokine/chemokine profiles indicate a more robust and sustained proinflammatory response contributing to better viral clearance and lower mortality in CD151 2/2 mice (which have relatively lower vial load, and thus less cellular infection and injury in the lungs). This is also congruent with the higher inflammatory cell infiltration score in these mice (Fig 3, L) . In contrast, the WT mice have comparatively lower cytokine/chemokine expression profile, but a relatively higher viral load and greater cellular infection and injury in the lungs, resulting in higher mortality. These cytokine profiles are consistent with our previous work on murine influenza pneumonia models. 17, 18 A key function that is mediated by the innate immune response system is the formation of the inflammasome. 20, 21 We observed a significant increase in transcripts of key inflammasome elements, including NLRP3 (also known as cryopyrin and NACHT, LRR, and PYD domains-containing protein 3), IL-1b, and IL-18 over the same period (Fig 3, M-O) . Although total caspase-1 was unchanged at the transcriptional level (Fig 3, P) , cleaved caspase-1, the core effector of NLRP3 inflammasome that mediates the maturation of IL-1b and IL-18, was significantly elevated in lung lysates of CD151 2/2 mice at 5 dpi (Fig 3, Q; see Fig E5 in this article's Online Repository at www.jacionline.org), indicating stronger inflammasome activation when CD151 is absent. Moreover, late-phase viral clearance (typically at 7 dpi) is highly dependent on the inflammasome complex that reduces damagecausing neutrophils and augments macrophage recruitment. [20] [21] [22] [23] Consistent with this, the levels of IL-18 remained high at 7 dpi in infected CD151 2/2 mice. Interestingly, caspase-1 gene expression correlated with the viral titer response where its expression was reduced at 3 and 9 dpi, respectively (compare Fig 3, P,  with Fig 1, C) .
Lack of CD151 modulates lung tissue damage induced by H1N1 infection
NLRP3-dependent caspase-1 activation and IL-1b secretion are associated with the promotion of tissue repair following an infection-induced injury by reducing the recruitment of damage-enhancing neutrophils and increasing the recruitment of repair-promoting macrophages. 23, 24 H1N1-infected CD151 2/2 mice exhibited comparable lung damage score during early infection at 3 dpi when compared with WT mice (Fig 4, A-C; see Fig E6, A, in this article's Online Repository at www.jacionline.org). In contrast, at 5 dpi when most of the inflammatory markers were significantly increased in lungs of CD151 2/2 mice, there was a concomitant increase in the percentage of damaged area in the infected lungs (Fig 4, A  and B; Fig E6, B) . At a later infection stage (7 and 9 dpi), consistent with the greater decline in expression of immune response genes in infected CD151 2/2 mice compared with WT mice, there was a statistically significant diminution of lung damage at 9 dpi following earlier viral clearance (Fig 4, A-C, and Fig E6, C and D) .
The development of severe influenza is linked not only to a heightened innate immune response but can also be partly attributed to the induction of endothelial permeability and activation, 25 and platelet adhesion to endothelial cells through integrins and fibronectin interactions.
26-28 Therefore, we investigated whether there was endothelial and platelet dysfunction given that CD151 expression is observed in these cell types. We found that the endothelial marker platelet endothelial cell adhesion molecule (also known as CD31) and endothelial-derived endothelin-1 were both upregulated at 5 dpi in lungs of CD151 2/2 mice (Fig 5, A and B) , which probably resulted from excessive cytokine production over the same period. Interestingly, we also observed significantly elevated expression of vascular cell adhesion molecule 1 (also known CD106) at 5 dpi in lungs of CD151 2/2 infected mice (Fig 5, C) , which may influence heightened lung damage score at 7 dpi that is resolved at 9 dpi. A, Representative H&E-stained images of mouse lung tissue at 3, 5, 7, and 9 dpi. Quantitative measurement of (B) % affected area of the lung and (C) lung tissue damage (pathology score, n 5 4 mice). *P < .05, compared with coresponding WT mice for the same dpi. H&E, Hematoxylin and eosin. the recruitment of inflammatory cells and contribute to virus clearance. The transcript expression of the platelet activation marker, the von willebrand factor, was significantly enhanced at 5 dpi in lungs of infected CD151 2/2 mice (Fig 5, D) . However, expression of its corresponding binding receptor, integrin aIIbb3, was unchanged at 5 dpi, and even slightly lower at 3 and 9 dpi relative to infected WT mice (Fig 5, E and F) . Thrombin, another marker of platelet activation, was not statistically altered across the infection period (Fig 5, G) . Enhanced platelet adhesion to endothelial cells via fibronectin and integrin binding is associated with higher mortality in a murine model of severe influenza. 27 Although we observed an upregulation of fibronectin at 5 dpi, its expression reverted to comparable levels at 7 and 9 dpi in infected CD151 2/ 2 versus WT mice (Fig 5, H) . The same trend was observed for the endothelial activation markers (Fig 5, A-D) . This implied that endothelial and platelet activation was well regulated, and thus may play an overall positive role in orchestrating the host immune responses against IAV infection in CD151 2/2 mice. Congruent with this, we confirmed that the difference in IAV-induced pathogenesis is not due to loss of tissue integrity as a consequence of CD151 inhibition. Although E-cadherin (Cdh1) expression was similar in CD151 2/2 and WT mice at 3 and 5 dpi, it was significantly higher in lungs of infected CD151 2/2 mice at 7 dpi (Fig  5, I ). This delayed upregulation of E-cadherin may reflect enhanced lung repair following augmented immune response to virus infection in CD151 2/2 mice. Hypoxia-inducible factor 1-alpha is induced by hypoxia and innate immune response in IAV-infected lungs, and is associated with the coordination of host defense to limit cell damage secondary to viral infection. 29 Hypoxiainducible factor 1-alpha was elevated at 5 dpi in lungs of infected CD151 2/2 mice, but later declined at 7 and 9 dpi (Fig 5, J) . Taken together, we summarized the key changes from the global ablation of CD151 during influenza infection (Fig 5, K) . On the basis of in vivo model, we propose that the improved survival of the CD151 2/2 mice was due to the early regulation of nuclear export of influenza virus RNPs, which culminated in the cascade of the series of downstream activation events that are beneficial to host survival.
CD151 interacts with and mediates nuclear export of host CRM1 and viral proteins (NP, M1, and NEP) in IAV-infected hNECs
To further ascertain the signaling mechanisms for the reduced viral titer despite lack of dramatic reduction in viral replication in the CD151 2/2 mice, we proceeded to explore the role of CD151 in human samples of hNECs cultured in ALI, comprising undifferentiated (stem), differentiating, and differentiated cells. We demonstrated that CD151 is expressed in both stem/progenitor and differentiated hNECs (see Fig E7, A, in this article's Online Repository at www.jacionline. org) with cytoplasmic and perinuclear expression (Fig E7, B) . In addition, siRNA treatment did not affect the differentiation of these cells nor their phenotype because p63 and a-tubulin expression was unchanged (Fig E7, A and C) . Western blot analysis verified that silencing of CD151 expression was successful (at siRNA concentration of 25 nM but not 12.5 nM) and specific because the protein expression of other tetraspanins (CD9 and CD81) was unchanged (Fig E7, D) . Viability studies showed that CD151 siRNA treatment had minimal cytotoxicity on hNECs (Fig E7,  E) . Importantly, CD151 knockdown efficiency and selectivity were sustained up to 24 hours postinfection (Fig E7, F and G) .
Despite interpatient variability among hNEC cultures from 7 independent donors, our data showed that when CD151 expression is downregulated (see Fig E7, A, and Fig E8, A, in this article's Online Repository at www.jacionline.org), there was a corresponding reduction in virus titer, suggesting that CD151 promotes IAV infectivity in hNECs (Fig E8, B; see Table E3 in this article's Online Repository at www.jacionline. org). However, CD151 knockdown in hNECs did not impact abundance of CRM1 and viral NP, M1, and NS1 proteins (Fig E8, C) . Immunofluorescence analysis revealed that in infected hNECs, CRM1 is predominantly perinuclear, whereas NP, M1, and NEP are predominantly cytoplasmic. However, upon CD151 siRNA, infected hNECs portrayed significant nuclear retention of NP, CRM1, M1, and NEP proteins (Fig 6, A-C , and Table E3 ). Consistent with this, the cellular distribution of viral NS1 (which is not involved in vRNPs nuclear export) was unaffected by CD151 knockdown (Fig 6, D, and Table E3 ). Moreover, NP and M1 expression was significantly elevated in the nuclear fraction but unchanged in the cytoplasmic fraction, which further supports the nuclear retention of the viral proteins in CD151 knockdown cells (Fig 6, E) .
Immunoprecipitation studies further demonstrated that CD151 (but not other tetraspanins such as CD9 and CD81) interacts with newly synthesized IAV proteins in H3N2-infected hNECs (Fig 6, F) . The binding of CD81 and CD9 was unaffected across all treatment conditions (Fig 6, F) . This was further supported by the reverse experiment, whereby CRM1, NP, and M1 were immunoprecipitated, and CD151 expression was probed by J ALLERGY CLIN IMMUNOL VOLUME 141, NUMBER 5
Western blotting (Fig 6, G) . Furthermore, the effects of CD151 were at the nuclear membrane and not at the cell membrane surface, because there was no immunoprecipitation of CD151 with viral cell surface markers hemagglutinin and vice versa (Fig 6, F and G) .
To ascertain whether CD151 functions as a key regulator of IAV vRNP export that is linked to antiviral and inflammatory gene expression or functions as a direct regulator of antiviral and inflammatory gene expression (innate immune response), we performed separate experiments with Poly (I:C) as a model of intracellular double-stranded RNA-induced antiviral responses without the involvement of viral spreading. Using established Poly (I:C) concentration and incubation timepoints, 30, 31 we showed that indeed expression levels of antiviral gene IFN-b, and inflammatory cytokines, IP-10 and IL-1b, were significantly upregulated by Poly (1:C) treatment whether or not cells had been treated with CD151 siRNA (see Fig E9 in this article' s Online Repository at www.jacionline.org). This finding supports the notion that effects of CD151 occur at the level of nuclear export of IAV whereby the reduction in IAV production from targeting CD151 indirectly contributes to altered immune responses.
CD151 inhibition increases a-tubulin in IAV-infected hNECs
Host microtubule proteins, a-and b-tubulins, are involved in the trafficking of virions to the plasma membrane following nuclear export. Interestingly, when CD151 expression was inhibited, infected hNECs displayed a further increase in a-tubulin abundance (Fig 7, A, and Table E3 ), whereas the abundance of b4-tubulin and F-actin (also a cytoskeletal protein but not part of the host microtubule complex) remained unchanged (Fig 7, B and C, and Table E3 ).
DISCUSSION
Despite advances in our understanding of the mechanism of IAV infection, the crucial virus-host interactions during the viral replication cycle still remain incomplete, and thus highlight the need to further elucidate these interactions for potential intervention. We showed that virus-host interactions mediated by CD151 are critical for the virus life cycle, and for the first time, implicated a functional role for CD151 in mediating the nuclear export of IAV proteins. In our infection models, silencing of CD151 expression retains CRM1, NP, M1, and NEP in the nucleus, resulting in inhibition of nuclear export and subsequent assembly of viral progenies. We also confirmed that CD151 can interact with these proteins. Because IAV was still able to enter host cells and be transported into the nucleus in the presence of CD151 siRNA (as observed by NP nuclear staining of infected hNECs and mouse lung sections), we propose that CD151 does not mediate virus uncoating, but rather mediates nuclear export of progeny viruses. Our data support the notion of targeting CD151 as an attractive strategy in combating IAV because it regulates most components (NP, M1, and NEP) required for the nuclear export of newly synthesized virions, making this regulation unique and not limited to single viral protein, which decreases the likelihood of escape mutants.
For progeny viruses to assemble and exit host cells, viral proteins need to be transported to the apical surface of the plasma membrane, 32 which requires stable microtubule formation by tubulins and their interaction with viral proteins such as NP. 33, 34 We demonstrated that inhibition of CD151 expression further enhances a-tubulin abundance, which may destabilize the microtubule complex, and hence affect the polarized viral protein trafficking leading to inefficient IAV progeny assembly. This is the first study to reveal that CD151 can influence microtubule protein expression during IAV infection. Future work could explore the effect of CD151 on posttranslational modifications of a-tubulin (eg, acetylation), which are important for microtubule stability. By measuring the gene expression of key host immune response markers recently identified in IAV-infected hNECs, 14 we demonstrated that CD151-mediated reduction in IAV production indirectly influences acute immune responses, which may account for the significantly improved survival rate of IAV-infected CD151 2/2 mice. Congruent with this, CD151 deficiency-mediated viral reduction significantly increased mRNA levels of antiviral mediators at 5 dpi, including IFN-g, ISGs (IFITM1 and IFITM), and CXCL10 (IP-10), which are critical in inhibiting virus replication during the early infection stage. 35, 36 This upregulated expression may facilitate virus clearance to improve survival. Notably, at 3 dpi, the expression of most antiviral molecules was not statistically different, suggesting that the reduction in virus titer is mainly mediated by the direct CD151-viral interaction in the virus nuclear export process. In support, we observed no significant difference in antiviral or inflammatory gene expression following Poly (I:C) stimulation in CD151 siRNA-treated epithelial cells, strengthening our proposal that CD151 does not directly alter antiviral and inflammatory gene expression in epithelial cells but that CD151 is critical for early regulation of IAV vRNP export and subsequent alteration of antiviral and inflammatory gene expression levels in epithelial cells. Whether CD151 deficiency directly influences responses of immune cells and adaptive immunity in IAV infection remains to be explored. The severity and pathogenesis of IAV infection were closely related to inflammation-induced lung damage due to the infection. Strikingly, CCL2 and CCL5 were significantly reduced in lungs of H1N1-infected CD151 2/2 mice at 3 dpi. These markers are related to cell death and aberrant innate immune response in macaques infected with 1918 H1N1 virus and in mice infected with highly virulent H3N2 virus. 17, 37 In addition, IL-13, another inflammatory marker, 38 was markedly reduced. These altered host immune factors corresponded with the reduced lung injury in H1N1-infected CD151 2/2 mice at 3 dpi. Intriguingly, at 5 dpi, we observed delayed but more robust inflammation in lungs of H1N1-infected CD151 2/2 mice, evident by significantly increased gene expression of IL-1b, TNF-a, CCL2, CCL5, IL-6, and IL-18. Nevertheless, although the inflammation was likely higher in CD151 2/2 mice, the lung pathology score was not statistically different, suggesting that CD151 2/2 mice experienced augmented inflammation through pathways that mitigate lung injury. Such modulation was evident through the increased mRNA expression of NLRP3 together with cleaved caspase-1 protein abundance, components of inflammasome associated with improvement in IAV infection, 23 which warrants further exploration into the underlying mechanisms as well as expression analysis of other potential inflammasome sensors such as AIM2, NLRP1, NLRC4, and RIG I. In addition, inflammasome or caspase-1 activation may be linked to the decreased infection of macrophages (thus favoring their survival and function) in the lungs of infected CD151 2/2 mice. Concerning NLRP3 and caspase-1 expression, these may also be related to the macrophage phenotype where M1 macrophages are less susceptible to IAV infection, and caspase-1 expression is upregulated in the M1 phenotype. Our previous work showed that caspase-1-deficient mice are more susceptible to H1N1 influenza pneumonia (40% mortality vs 10% in WT mice). 39, 40 Strikingly, the endothelial function was also activated in CD151 2/2 mice at 5 dpi, which was consistent with the heightened lung inflammation. As important orchestrators of the host immune response to IAV infection, activation of endothelial cells may play vital roles in promoting innate immunity for more rapid viral clearance on one hand, while on the other may induce lung pathology via platelet-endothelial interaction and platelet aggregation. [26] [27] [28] However, we did not observe any increase in platelet activation markers upon increase in adhesion molecules when CD151 is absent. Given that CD151 plays important roles in mediating clot formation and integrin functions, [41] [42] [43] deficiency in platelet aggregation in CD151 2/2 mice may in turn contribute to their improved survival and reduced pathology. Furthermore, at 7 and 9 dpi, the immune response and endothelial activation in CD151 2/2 mice significantly declined to comparable levels observed in WT mice, which may confer protection from further lung injury arising from prolonged inflammation. Overall, our findings link silencing of CD151 with upregulated but well-controlled innate immunity against IAV infection, which may be critical in improving the survival rate of CD151 2/2 mice. This is the first study that examined the role of CD151 in IAV infection of the respiratory tract. We focused on the initial IAV infection phase, that is, the nasal epithelium, which constitutes the first line of host defense for protecting against invading pathogens. 44 We used hNECs cultured in ALI, which form a pseudostratified epithelium, vastly distinct from commercially available immortalized respiratory monolayer cell cultures, which may not represent the authentic biological features of the nasal epithelium. [45] [46] [47] Building on our in vivo model that provided evidence that the CD151 knockout phenotype can protect the murine respiratory tract from IAV infection, the in vitro model further confirmed the mechanism of CD151 in the nuclear export of vRNP. This model also revealed that CD151 interacts with NP among hNEC samples derived from different individuals. Besides nuclear export, NP is involved in multiple viral processes (transcription, replication, and maturation), and hence NP levels in the infected mice are indicative of IAV infection severity. A key difference between the models is that we observed a reduction in NP in the mouse lungs in vivo, which is distinct from our in vitro study. This may be attributed to the longer study period and the complex regulatory pathways governed by CD151 in a whole animal compared with individual cells. We observed consistent reductions in virus titer and signaling mechanism of both human H3N2 and murine H1N1 strains when CD151 expression was curtailed. This implies a universally important functional role of CD151 across IAV strains infecting both upper and lower respiratory tracts, which could be a target for intervention in view of the constant influenza pandemic threat and increasing emergence of drug-resistant strains. mAbs targeting CD151 are commercially available and have shown promising antimetastatic results in mice. 48 Furthermore, animal studies have shown that anticonvulsant and analgesic drugs, such as carbamazepine and valproate, can reduce CD151 mRNA expression with chronic administration. 49 Given that CD151 2/2 mice are viable and healthy, we anticipate that adverse effects resulting from agents that target CD151 expression in humans will be negligible, thus opening up possibilities to explore the use of anti-CD151 agents in humans as effective prophylaxis during major influenza outbreaks.
